Clinical Trial

Randomised Trial Comparing Thermal Ablation With Adrenalectomy in the Treatment of Unilateral Asymmetric PA

Study acronym: WAVE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of WAVE is to test the hypothesis that thermal ablation (microwave or RFA) is non-inferior to surgery in the biochemical (and if so, in the clinical) cure of unilateral PA, according to the international consensus PASO criteria. Secondary objectives are to determine whether either intervention is superior to the other in relation to the following outcomes. Where no superiority of either intervention is established, non-inferiority of thermal ablation against adrenalectomy will be sought. * Frequency and severity of adverse events * Length of inpatient stay * Patient satisfaction * Quality of life * Return to activities of daily living An additional secondary objective in the thermal ablation group alone will be anatomical efficacy of ablation.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-19
notable Primary completion pushed: 2026-06-01 -> 2026-11-01 2026-07-19
minor Completion pushed: 2026-09-01 -> 2026-11-01 2026-07-19
Trial Details
NCT Number NCT05405101
Lead Sponsor Queen Mary University of London
Conditions Primary Aldosteronism
Enrollment 112 participants
Start Date 2022-09-01
Primary Completion 2026-11-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-17